Filing Details

Accession Number:
0001099800-10-000003
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-10 17:59:22
Reporting Period:
2010-11-08
Filing Date:
2010-11-10
Accepted Time:
2010-11-10 17:59:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1099800 Edwards Lifesciences Corp EW Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 364316614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204553 Huimin Wang C/O Edwards Lifesciences
One Edwards Way
Irvine CA 92614
Cvp, Japan & Intercontinetal No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-08 13,700 $13.00 67,626 No 4 M Direct
Common Stock Disposition 2010-11-08 14 $66.19 53,926 No 4 S Direct
Common Stock Acquisiton 2010-11-09 6,300 $13.00 60,226 No 4 M Direct
Common Stock Disposition 2010-11-09 6,300 $66.18 53,926 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Acquire) Disposition 2010-11-08 13,700 $0.00 13,700 $13.00
Common Stock Employee Stock Option (Right to Acquire) Disposition 2010-11-09 6,300 $0.00 6,300 $13.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,300 2003-05-05 2012-05-07 No 4 M Direct
0 2003-05-08 2010-05-07 No 4 M Direct
Footnotes
  1. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
  2. This transaction was executed in multiple trades at prices ranging from $66.18 to $66.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.